MaxCyte, Inc. (MXCT) Earnings History
Annual and quarterly earnings data from 2012 to 2025
Loading earnings history...
MXCT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MXCT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 81.2% | -138.3% | -135.1% |
| 2024 | 81.6% | -132.5% | -106.3% |
| 2023 | 88.5% | -117.0% | -91.8% |
| 2022 | 88.5% | -61.8% | -53.3% |
| 2021 | 89.2% | -53.7% | -56.3% |
Download Data
Export MXCT earnings history in CSV or JSON format
Free sign-in required to download data
MaxCyte, Inc. (MXCT) Earnings Overview
As of May 8, 2026, MaxCyte, Inc. (MXCT) reported trailing twelve-month net income of -$45M, reflecting -7.7% year-over-year growth. The company earned $-0.42 per diluted share over the past four quarters, with a net profit margin of -135.1%.
Looking at the long-term picture, MXCT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$958,200 in fiscal 2013.
MaxCyte, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BTBT ($137M net income, 17.3% margin), LNTH ($279M net income, 15.2% margin), NVAX (-$88M net income, 39.2% margin), MXCT has room to improve margins relative to the peer group. Compare MXCT vs BTBT →
MXCT Earnings vs Peers
Earnings metrics vs comparable public companies
MXCT Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$45M | -8.7% | -$46M | $-0.42 | -135.1% | -138.3% |
| 2024 | -$41M | -8.3% | -$51M | $-0.39 | -106.3% | -132.5% |
| 2023 | -$38M | -60.9% | -$48M | $-0.37 | -91.8% | -117.0% |
| 2022 | -$24M | -23.5% | -$27M | $-0.19 | -53.3% | -61.8% |
| 2021 | -$19M | -61.5% | -$18M | $-0.22 | -56.3% | -53.7% |
| 2020 | -$12M | +8.4% | -$11M | $-0.18 | -45.2% | -42.3% |
| 2019 | -$13M | -45.4% | -$12M | $-0.24 | -59.6% | -57.4% |
| 2018 | -$9M | +10.6% | -$8M | $-0.17 | -53.2% | -50.5% |
| 2017 | -$10M | -196.4% | -$9M | $-0.20 | -70.9% | -66.4% |
| 2016 | -$3M | -131.4% | -$3M | $-0.10 | -27.3% | -22.2% |
See MXCT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MXCT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MXCT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMXCT — Frequently Asked Questions
Quick answers to the most common questions about buying MXCT stock.
Is MXCT growing earnings?
MXCT EPS fell to $-0.42, with earnings declining -7.7%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-45M.
What are MXCT's profit margins?
MaxCyte, Inc. net margin is -135.1%, with operating margin at -138.3%. Below-average margins reflect competitive or cost pressures.
How consistent are MXCT's earnings?
MXCT earnings data spans 2012-2025. The declining earnings trend is -7.7% YoY. Historical data enables comparison across business cycles.